Target intelligence / Profile preview

SDCBP2 antisense RNA 1 (SDCBP2-AS1)

Target
SDCBP2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Other (non-protein-coding RNA)
01

Overview

SDCBP2 antisense RNA 1 (SDCBP2-AS1) is a long non-coding RNA (lncRNA) gene that regulates various cellular processes including cell proliferation, migration, and apoptosis[1][2]. It functions primarily by interacting with proteins (such as hnRNP K and YBX1) and acting as a sponge for microRNAs, thereby influencing gene expression[1][2]. SDCBP2-AS1 has been shown to suppress tumorigenesis and metastasis in gastric cancer by destabilizing β-catenin and inhibiting oncogenic pathways[2]. Expression levels of SDCBP2-AS1 may serve as a prognostic marker in certain cancers such as gastric and ovarian cancer, and it is considered a potential target for therapeutic intervention, though no drugs currently directly target this molecule[2][1][3].

Other names
SDCBP2 antisense RNA 1 (non-protein coding)SDCBP2-AS1syndecan-binding protein 2 antisense RNA 1HGNC:44314NCBI Gene:100507495Ensembl:ENSG00000234684
02

Mechanism of action

Therapeutic modulation often proposed via RNA interference, antisense oligonucleotides, or targeted RNA delivery, but none directly approved or widely used

03

Biological functions

Cell proliferationCell migrationApoptosisRegulation of gene expression post-transcriptionally (e.g., through interaction with proteins or as a microRNA sponge)
04

Disease associations

Cancer (including gastric cancer, ovarian cancer)Glioma susceptibilityOther (potential but not yet fully characterized disease associations)
05

Safety considerations

Therapeutic targeting of lncRNAs may pose risks of off-target effects and immune activationNeed for further safety evaluation in clinical translation
06

Biomarkers

Prognostic biomarker for gastric cancer survivalMarker for cell proliferation and metastasis in certain cancers

Beyond the preview

Go deeper on SDCBP2 antisense RNA 1 (SDCBP2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SDCBP2 antisense RNA 1 (SDCBP2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call